We use cookies to help provide you with the best possible online experience. Learn more
Press archive

    Mitchell Cancer Institute, US, selects RayStation for TomoTherapy

    PDF

    The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Alabama, has selected RayStation* as its treatment planning system for the TomoTherapy ® System. The center also treats patients using a CyberKnife ®System and will use RayStation* for this in the future.

    MCI’s radiation therapy service is equipped with state-of-the-art Accuray´s CyberKnife and TomoTherapy System, as well as a 64-slice PET-CT scanner. The center was initially interested in RayStation’s forthcoming support for the CyberKnife System, but quickly saw that the system could meet all of its treatment planning needs into the future, including the TomoTherapy System.

    Dr. Weisi Yan, Director of the CyberKnife Program at MCI, says: “We were very impressed by the capabilities and user-friendliness of RayStation. As a leading-edge treatment center, we need the best possible technology in order to deliver outstanding care and maximize efficiency. RayStation will help us to achieve our goals.”

    Hal Hopper, Manager of MCI’s Department of Radiation Oncology, says: “RayStation is fast and effective in planning treatments for all possible techniques we are likely to offer. It is much less labor-intensive than other systems we have used. With RayStation, the physician can choose the best course of treatment more quickly.”

    Johan Löf, CEO of RaySearch, says: “MCI shares our vision of continuously advancing cancer treatment. We are very pleased to be able to meet their requirements for advanced clinical techniques as well as optimized workflows and use of resources.”
        

    About MCI
    Founded in 2000, MCI provides cancer treatment in three locations: MCI headquarters in Mobile, the MCI Kilborn Clinic in Fairhope and Monroe County Hospital in Monroeville. The center’s researchers and clinicians focus daily on the battle against cancer serving a potential catchment population of more 4.1 million people, with a singular focus of advancing cancer diagnosis, treatment and prevention in the region and beyond. Since its establishment, the center’s strategic goal has remained constant: to achieve competitiveness for future designation as an NCI Comprehensive Cancer Center and to achieve self-sustaining, long-term financial viability.

    About RayStation
    RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy*. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

    About RaySearch
    RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company recently launched the next-generation oncology information system, RayCare*, which comprises a new product area for RaySearch. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.

    To learn more about RaySearch, go to: www.raysearchlabs.com

    * Subject to regulatory clearance in some markets.

    For further information, please contact:
    Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
    Telephone: +46 (0)8-510 530 00
    johan.lof@raysearchlabs.com 

    PDF